Genetic analysis of lung cancer susceptibility
Genetic analysis of lung cancer susceptibility
批准号:
10322757
负责人:
Christopher I. Amos
金额:
$8.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-01 至 2022-12-31
关键词:
AsiaBiological MarkersBiologyCancer EtiologyChemopreventive AgentCollaborationsCollectionColon CarcinomaCommunitiesDataDevelopmentDideoxy Chain Termination DNA SequencingEnrollmentEthnic groupEtiologyEuropeFamily history ofGeneticGenetic Predisposition to DiseaseGenetic studyGenotypeGeographyHeritabilityImage AnalysisIndividualIntegration Host FactorsInternationalInterventionJointsKnowledgeLungMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMendelian randomizationModelingNorth AmericaParentsParticipantPatient RecruitmentsPatientsPlayPopulationPredispositionProxyPublic HealthResourcesRiskRisk AssessmentRisk FactorsRoleSample SizeSamplingSiteSmokerSmoking BehaviorSouth AmericaStatistical Data InterpretationSubgroupSusceptibility GeneTechnologyVariantVitamin B 12Workbiobankbiomarker evaluationcancer riskcase controldatabase of Genotypes and Phenotypesdesignepidemiology studyexperiencegenetic analysisgenetic architecturegenetic informationgenetic predictorsgenetic resourcegenetic variantgenome wide association studygenome-widegenome-wide analysishigh riskimprovedinsightmalignant breast neoplasmmortalitynovelpolygenic risk scorepopulation basedprediction algorithmprogramsrisk predictionscreeningsmoking cessationtobacco exposuretumorvalidation studies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Although tobacco exposure is the major determinant of lung cancer, only about 15% of smokers
develop lung cancer. In this study, we seek to identify genetic effects that influence lung cancer
risk, either independently or jointly with smoking behavior. We hypothesize that novel genetic
and host factors influencing the susceptibility for lung cancer can be identified
by genotyping. We will pursue 3 aims. In Aim 1 we will (a) Genotype on bead arrays an
23,103 lung cancer cases and 23,103 unrelated controls on genome wide arrays in order to
identify genetic variants and (b) Validate selected SNPs in additional populations.
Validation studies will be conducted for selected variants to assure results are consistent
between genotyping or Sanger sequencing analysis. In Aim 2, we will Evaluate strength
of genetic effects using the additional genotypes generated in aim (1) and combine
with our existing 29,683 lung cancer cases and 55,586 controls. In this aim, we take
advantage of the larger population of samples to impute variants and perform
association analyses for inferred variants for a much larger collection. Finally in Aim 4,
we will Construct a risk prediction algorithm to improve the accuracy of the current lung
cancer risk models. These models will be valuable for refining the selection of individuals to
be enrolled in lung screening studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study
-
批准号:10608848
-
项目类别:
-
资助金额:$70.02万
-
财政年份:2023
-
负责人:Christopher I. Amos
-
依托单位:
Data & Analysis Core
-
批准号:10657451
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2022
-
负责人:Christopher I. Amos
-
依托单位:
Data & Analysis Core
-
批准号:10410755
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2022
-
负责人:Christopher I. Amos
-
依托单位:
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling
-
批准号:10436886
-
项目类别:
-
资助金额:$58.13万
-
财政年份:2020
-
负责人:Christopher I. Amos
-
依托单位:
Sequencing Familial Lung Cancer
-
批准号:9916400
-
项目类别:
-
资助金额:$73.51万
-
财政年份:2020
-
负责人:Christopher I. Amos
-
依托单位:
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling
-
批准号:9916850
-
项目类别:
-
资助金额:$67.86万
-
财政年份:2020
-
负责人:Christopher I. Amos
-
依托单位:
Sequencing Familial Lung Cancer
-
批准号:10318921
-
项目类别:
-
资助金额:$64.21万
-
财政年份:2020
-
负责人:Christopher I. Amos
-
依托单位:
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling
-
批准号:10650289
-
项目类别:
-
资助金额:$56.87万
-
财政年份:2020
-
负责人:Christopher I. Amos
-
依托单位:
Sequencing Familial Lung Cancer
-
批准号:10548750
-
项目类别:
-
资助金额:$64.21万
-
财政年份:2020
-
负责人:Christopher I. Amos
-
依托单位:
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling
-
批准号:10207552
-
项目类别:
-
资助金额:$60.89万
-
财政年份:2020
-
负责人:Christopher I. Amos
-
依托单位:
PIPELINE Facility Core
-
批准号:10390324
-
项目类别:
-
资助金额:$11.37万
-
财政年份:2019
-
负责人:Christopher I. Amos
-
依托单位:
Precision approaches to refining TP53-associated cancer risk
-
批准号:10020352
-
项目类别:
-
资助金额:$171.33万
-
财政年份:2019
-
负责人:Christopher I. Amos
-
依托单位:
Precision approaches to refining TP53-associated cancer risk
-
批准号:9815261
-
项目类别:
-
资助金额:$170.41万
-
财政年份:2019
-
负责人:Christopher I. Amos
-
依托单位:
Precision approaches to refining TP53-associated cancer risk
-
批准号:10693974
-
项目类别:
-
资助金额:$170.93万
-
财政年份:2019
-
负责人:Christopher I. Amos
-
依托单位:
PIPELINE Facility Core
-
批准号:10647901
-
项目类别:
-
资助金额:$11.37万
-
财政年份:2019
-
负责人:Christopher I. Amos
-
依托单位:
Precision approaches to refining TP53-associated cancer risk
-
批准号:10248481
-
项目类别:
-
资助金额:$170.51万
-
财政年份:2019
-
负责人:Christopher I. Amos
-
依托单位:
Genomic predictors of smoking and lung cancer risk
-
批准号:9657408
-
项目类别:
-
资助金额:$85.13万
-
财政年份:2018
-
负责人:Christopher I. Amos
-
依托单位:
Genomic predictors of smoking and lung cancer risk
-
批准号:10374813
-
项目类别:
-
资助金额:$84.57万
-
财政年份:2017
-
负责人:Christopher I. Amos
-
依托单位:
Admin-Core-001
-
批准号:10493996
-
项目类别:
-
资助金额:$22.81万
-
财政年份:2017
-
负责人:Christopher I. Amos
-
依托单位:
Integrative analysis of lung cancer etiology and risk
-
批准号:9518575
-
项目类别:
-
资助金额:$230.62万
-
财政年份:2017
-
负责人:Christopher I. Amos
-
依托单位:
海外基金